Filtered By:
Source: Reuters: Health
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 111 results found since Jan 2013.
With stimulant, kids with ADHD less likely to injure themselves
(Reuters Health) – When kids with attention-deficit hyperactivity disorder (ADHD) are taking methylphenidate, a stimulant drug, they are less likely to end up in the emergency room with a trauma injury, a new study finds.
Source: Reuters: Health - December 18, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Alcobra's ADHD drug meets goals, after excluding some data
(Reuters) - Alcobra Ltd said its drug to treat adult attention deficit disorder met the main goals of a late-stage trial - but only after excluding data from four patients who reacted positively to a placebo.
Source: Reuters: Health - October 6, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
One in four kids on ADHD meds gets therapy too
NEW YORK (Reuters Health) - Most kids in the U.S. who take medication for attention deficit hyperactivity disorder (ADHD) are not getting behavioral counseling therapy as well, according to a new study.
Source: Reuters: Health - September 25, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Using a nicotine patch during pregnancy tied to higher ADHD risk
NEW YORK (Reuters Health) - Smoking during pregnancy has been linked to a higher chance of the child having attention-deficit/hyperactivity disorder (ADHD), and a new study suggests women who use nicotine replacement products may also have children with an elevated risk.
Source: Reuters: Health - July 22, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Shire to test its ADHD drug in 4 to 5-year olds in U.S.
WASHINGTON (Reuters) - Shire Plc SHP.L has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmaker said on Thursday.
Source: Reuters: Health - June 13, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Shire agrees to test its ADHD drug in preschool children
LONDON (Reuters) - London-listed drugmaker Shire PLC said it had agreed to a request from the U.S. regulator to test the use of its amphetamine-based drug Vyvanse in preschool children aged four and five with hyperactivity.
Source: Reuters: Health - June 12, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
ADHD medications tied to teenage weight gain
NEW YORK (Reuters Health) - Stimulant medications, rather than the childhood ADHD they are used to treat, could be linked to weight gain during the teenage years, according to a new analysis of medical records.
Source: Reuters: Health - March 18, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Childhood ADHD linked to obesity in teens
NEW YORK (Reuters Health) - Having attention-deficit/hyperactivity disorder (ADHD) may put children at higher risk of becoming obese in adolescence, a new study suggests.
Source: Reuters: Health - March 5, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Wider ADHD definition risks unnecessary medication, say experts
LONDON (Reuters) - A wider definition of attention deficit hyperactivity disorder (ADHD) is causing inappropriate diagnosis and unnecessary and possibly harmful medical treatment costing up to $500 million in the United States alone, scientists said on Wednesday.
Source: Reuters: Health - November 5, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Shire's ADHD drug succeeds in trial to treat binge eating
LONDON (Reuters) - Pharmaceutical group Shire PLC said Vyvanse, its amphetamine-based drug prescribed to U.S. students to control ADHD, had also been successful in treating the newly-recognized binge eating disorder (BED) in a trial.
Source: Reuters: Health - November 5, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Parents' ADHD goals tied to treatment choices: study
NEW YORK (Reuters Health) - Parents' goals and concerns for their children with attention-deficit/hyperactivity disorder may influence their decision to start behavior therapy or medication, according to a new study that researchers say supports a shared decision-making approach to ADHD treatment.
Source: Reuters: Health - September 2, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
ADHD, texting a dangerous driving combination: study
NEW YORK (Reuters Health) - Teens with attention-deficit/hyperactivity disorder drive at a less consistent speed and spend more time out of their lane than young drivers without ADHD, according to a study that suggests texting at the wheel only makes the situation worse.
Source: Reuters: Health - August 13, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Addictive gaming more common with autism and ADHD
NEW YORK (Reuters Health) - Children with an autism spectrum disorder spend about twice as much time playing video games as kids who don't have a developmental disability, according to a new study.
Source: Reuters: Health - July 31, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Fewer minority kids diagnosed with ADHD
NEW YORK (Reuters Health) - Black and Hispanic children are half as likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) as their white peers, according to a new study that followed U.S. kindergarteners through middle school.
Source: Reuters: Health - June 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
ADHD medications not tied to drug, alcohol abuse
NEW YORK (Reuters Health) - Taking Ritalin and other drugs for attention-deficit/hyperactivity disorder (ADHD) doesn't affect a child's chances of trying or abusing alcohol and drugs later in life, a new review suggests.
Source: Reuters: Health - May 29, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
